BRPI0513793A - composto ou sal farmaceuticamente aceitável do mesmo, método de tratamento de uma condição em um mamìfero, formulação farmacêutica, e, composição farmacêutica - Google Patents
composto ou sal farmaceuticamente aceitável do mesmo, método de tratamento de uma condição em um mamìfero, formulação farmacêutica, e, composição farmacêuticaInfo
- Publication number
- BRPI0513793A BRPI0513793A BRPI0513793-4A BRPI0513793A BRPI0513793A BR PI0513793 A BRPI0513793 A BR PI0513793A BR PI0513793 A BRPI0513793 A BR PI0513793A BR PI0513793 A BRPI0513793 A BR PI0513793A
- Authority
- BR
- Brazil
- Prior art keywords
- treating
- condition
- pharmaceutically acceptable
- mammal
- salt
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 title 1
- -1 AND Substances 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 206010003119 arrhythmia Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59218104P | 2004-07-29 | 2004-07-29 | |
| PCT/US2005/026334 WO2006028590A1 (en) | 2004-07-29 | 2005-07-25 | 1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri (hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0513793A true BRPI0513793A (pt) | 2008-05-13 |
Family
ID=35613661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0513793-4A BRPI0513793A (pt) | 2004-07-29 | 2005-07-25 | composto ou sal farmaceuticamente aceitável do mesmo, método de tratamento de uma condição em um mamìfero, formulação farmacêutica, e, composição farmacêutica |
Country Status (15)
| Country | Link |
|---|---|
| KR (1) | KR20070043985A (ru) |
| AR (1) | AR049847A1 (ru) |
| BR (1) | BRPI0513793A (ru) |
| CR (1) | CR8876A (ru) |
| EC (1) | ECSP077208A (ru) |
| IL (1) | IL180846A0 (ru) |
| MA (1) | MA28980B1 (ru) |
| MX (1) | MX2007001188A (ru) |
| NO (1) | NO20071107L (ru) |
| PE (1) | PE20060382A1 (ru) |
| RU (1) | RU2344134C2 (ru) |
| TW (1) | TW200607493A (ru) |
| UA (1) | UA88018C2 (ru) |
| WO (1) | WO2006028590A1 (ru) |
| ZA (1) | ZA200700477B (ru) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2755569A1 (en) * | 2009-03-18 | 2010-09-23 | Medicure International Inc. | Transdermal pharmaceutical preparation and administration of tirofiban |
| AU2013274619B2 (en) | 2012-06-11 | 2017-09-28 | Bristol-Myers Squibb Company | Phosphoramidic acid prodrugs of 5 - [5 - phenyl- 4 - (pyridin- 2 - ylmethylamino) quinazolin- 2 - yl] pyridine- 3 - sulfonamide |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2140865B2 (de) * | 1971-08-14 | 1979-10-11 | Bayer Ag, 5090 Leverkusen | 1 -Imidazolyl-methanphosphonsäureester, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel |
| DE19951701A1 (de) * | 1999-10-27 | 2001-05-03 | Aventis Pharma Gmbh | Verwendung von 2-Imidazolyl-substituierten Carbinolen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten |
| DE60322019D1 (de) * | 2002-01-04 | 2008-08-21 | Neurosearch As | Kaliumkanal-modulatoren |
-
2005
- 2005-07-19 AR ARP050102975A patent/AR049847A1/es unknown
- 2005-07-22 PE PE2005000858A patent/PE20060382A1/es not_active Application Discontinuation
- 2005-07-22 TW TW094125011A patent/TW200607493A/zh unknown
- 2005-07-25 UA UAA200702125A patent/UA88018C2/ru unknown
- 2005-07-25 BR BRPI0513793-4A patent/BRPI0513793A/pt not_active IP Right Cessation
- 2005-07-25 KR KR1020077002228A patent/KR20070043985A/ko not_active Withdrawn
- 2005-07-25 RU RU2007107408/04A patent/RU2344134C2/ru not_active IP Right Cessation
- 2005-07-25 WO PCT/US2005/026334 patent/WO2006028590A1/en not_active Ceased
- 2005-07-25 MX MX2007001188A patent/MX2007001188A/es unknown
-
2007
- 2007-01-16 ZA ZA200700477A patent/ZA200700477B/xx unknown
- 2007-01-21 IL IL180846A patent/IL180846A0/en unknown
- 2007-01-25 CR CR8876A patent/CR8876A/es not_active Application Discontinuation
- 2007-01-26 EC EC2007007208A patent/ECSP077208A/es unknown
- 2007-02-21 MA MA29689A patent/MA28980B1/fr unknown
- 2007-02-27 NO NO20071107A patent/NO20071107L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2007107408A (ru) | 2008-09-10 |
| AR049847A1 (es) | 2006-09-06 |
| PE20060382A1 (es) | 2006-05-15 |
| NO20071107L (no) | 2007-04-19 |
| ECSP077208A (es) | 2007-02-28 |
| UA88018C2 (ru) | 2009-09-10 |
| CR8876A (es) | 2007-08-28 |
| IL180846A0 (en) | 2007-06-03 |
| ZA200700477B (en) | 2009-08-26 |
| MX2007001188A (es) | 2007-03-21 |
| RU2344134C2 (ru) | 2009-01-20 |
| KR20070043985A (ko) | 2007-04-26 |
| WO2006028590A1 (en) | 2006-03-16 |
| MA28980B1 (fr) | 2007-11-01 |
| TW200607493A (en) | 2006-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20071042L (no) | 5-substituerte 2-fenylaminobenzamider som MEK-inhibitorer | |
| BRPI0515500A (pt) | derivados piridazina para inibição de estearoil-coa-desaturase | |
| EA201101672A1 (ru) | Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина | |
| EA201100750A1 (ru) | Замещенные диоксопиперидинилфталимидные производные | |
| MX340965B (es) | Combinaciones para el tratamiento de enfermedades que involucran la proliferacion celular. | |
| EA201001455A1 (ru) | Пиридины и пиразины в качестве ингибиторов pi3k (фосфатидилинозиткиназы-3) | |
| EA200702387A1 (ru) | Имидазохинолины в качестве ингибиторов липидкиназы | |
| MX2009004475A (es) | Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma. | |
| ECSP067076A (es) | Derivados de pirimidina urea como inhibidores de la quinasa | |
| EA200971081A1 (ru) | Пуриновые производные и их применение в качестве модуляторов толл-подобного рецептора 7 | |
| BRPI0507198A (pt) | derivados de bisariluréia | |
| AR067495A1 (es) | Composiciones farmaceuticas y procedimientode tratamientos de trastornos de ojo seco | |
| BRPI0512193B8 (pt) | composto ou sal farmaceuticamente aceitável, composição farmacêutica, e, uso do composto ou sal | |
| BR0309343A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas | |
| EA201170607A1 (ru) | Акриламидопроизводные, применимые как ингибиторы перехода митохондриальной проницаемости | |
| BRPI0517567A (pt) | composto ou um sal, solvato, ou derivado fisiologicamente funcional farmaceuticamente aceitável do mesmo, composição farmacêutica, usos de um composto ou um sal, solvato, ou derivado fisiologicamente funcional farmaceuticamente aceitável do mesmo e de uma composição farmacêutica, e, processo para preparar um composto | |
| BRPI0508540A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0606793A8 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, processo para a preparação e uso do mesmo, métodos para a inibição da atividade de trk, para o tratamento ou profilaxia de câncer e para a produção de um efeito anti-proliferativo em um animal de sangue quente, e, composição farmacêutica | |
| BR0309342A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas | |
| EA201001196A1 (ru) | Соединения 4-пиридинона и их применение для лечения рака | |
| CY1109763T1 (el) | Υλικα και μεθοδος για τη θεραπεια διαταραχων πηξης | |
| NO20076357L (no) | Azabicykliske heterocykler som cannabinoid reseptor modulatorer | |
| MX2010007584A (es) | Inhibidores de proteina cinasa y uso de los mismos. | |
| BR112013007343A2 (pt) | métodos para tratar eritema associado com rosácea e para tratar telangiectasia associada com rosácea, e, composição tópica | |
| DE602005013793D1 (de) | Thiazolderivate mit vap-1-hemmender wirkung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |